Literature DB >> 26233928

Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis.

Taylor A Doherty1, Rachel Baum2, Robert O Newbury3, Tom Yang4, Ranjan Dohil5, Melissa Aquino4, Ashmi Doshi6, Hannah H Walford6, Richard C Kurten7, David H Broide2, Seema Aceves4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26233928      PMCID： PMC4562810          DOI： 10.1016/j.jaci.2015.05.048

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

1.  Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis.

Authors:  Iris M Otani; Arjun A Anilkumar; Robert O Newbury; Monica Bhagat; Lisa Y Beppu; Ranjan Dohil; David H Broide; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2013-04-25       Impact factor: 10.793

Review 2.  Eosinophilic esophagitis.

Authors:  Seema S Aceves
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

3.  Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161.

Authors:  Jenny M Mjösberg; Sara Trifari; Natasha K Crellin; Charlotte P Peters; Cornelis M van Drunen; Berber Piet; Wytske J Fokkens; Tom Cupedo; Hergen Spits
Journal:  Nat Immunol       Date:  2011-09-11       Impact factor: 25.606

Review 4.  At the bench: understanding group 2 innate lymphoid cells in disease.

Authors:  Taylor A Doherty
Journal:  J Leukoc Biol       Date:  2014-12-03       Impact factor: 4.962

5.  Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33.

Authors:  Christina A Christianson; Nicholas P Goplen; Iram Zafar; Chaoyu Irvin; James T Good; Donald R Rollins; Balachandra Gorentla; Weimin Liu; Magdalena M Gorska; HongWei Chu; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2015-01-21       Impact factor: 10.793

6.  The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells.

Authors:  Jenny Mjösberg; Jochem Bernink; Korneliusz Golebski; Julien J Karrich; Charlotte P Peters; Bianca Blom; Anje A te Velde; Wytske J Fokkens; Cornelis M van Drunen; Hergen Spits
Journal:  Immunity       Date:  2012-10-11       Impact factor: 31.745

7.  Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma.

Authors:  Cindy Barnig; Manuela Cernadas; Stefanie Dutile; Xiaoli Liu; Mark A Perrella; Shamsah Kazani; Michael E Wechsler; Elliot Israel; Bruce D Levy
Journal:  Sci Transl Med       Date:  2013-02-27       Impact factor: 17.956

8.  IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids.

Authors:  Carine Blanchard; Melissa K Mingler; Maria Vicario; J Pablo Abonia; Yi Ying Wu; Thomas X Lu; Margaret H Collins; Philip E Putnam; Susanne I Wells; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2007-12       Impact factor: 10.793

9.  TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation.

Authors:  Brian S Kim; Mark C Siracusa; Steven A Saenz; Mario Noti; Laurel A Monticelli; Gregory F Sonnenberg; Matthew R Hepworth; Abby S Van Voorhees; Michael R Comeau; David Artis
Journal:  Sci Transl Med       Date:  2013-01-30       Impact factor: 17.956

10.  An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation.

Authors:  Christoph Wilhelm; Keiji Hirota; Benjamin Stieglitz; Jacques Van Snick; Mauro Tolaini; Katharina Lahl; Tim Sparwasser; Helena Helmby; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2011-10-09       Impact factor: 25.606
  10 in total
  45 in total

Review 1.  The Immunologic Mechanisms of Eosinophilic Esophagitis.

Authors:  David A Hill; Jonathan M Spergel
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

Review 2.  Biological therapies for eosinophilic gastrointestinal diseases.

Authors:  Joshua B Wechsler; Ikuo Hirano
Journal:  J Allergy Clin Immunol       Date:  2018-05-31       Impact factor: 10.793

Review 3.  Innate lymphoid cells: major players in inflammatory diseases.

Authors:  Mikaël Ebbo; Adeline Crinier; Frédéric Vély; Eric Vivier
Journal:  Nat Rev Immunol       Date:  2017-08-14       Impact factor: 53.106

4.  Local Antigen Deposition in Eosinophilic Esophagitis: Implications for Immune Activation.

Authors:  Seema S Aceves
Journal:  Gastroenterology       Date:  2019-05-28       Impact factor: 22.682

Review 5.  Pathophysiology of Eosinophilic Esophagitis.

Authors:  Kelly M O'Shea; Seema S Aceves; Evan S Dellon; Sandeep K Gupta; Jonathan M Spergel; Glenn T Furuta; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2017-07-27       Impact factor: 22.682

Review 6.  Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis.

Authors:  Lei Cheng; Jianjun Chen; Qingling Fu; Shaoheng He; Huabin Li; Zheng Liu; Guolin Tan; Zezhang Tao; Dehui Wang; Weiping Wen; Rui Xu; Yu Xu; Qintai Yang; Chonghua Zhang; Gehua Zhang; Ruxin Zhang; Yuan Zhang; Bing Zhou; Dongdong Zhu; Luquan Chen; Xinyan Cui; Yuqin Deng; Zhiqiang Guo; Zhenxiao Huang; Zizhen Huang; Houyong Li; Jingyun Li; Wenting Li; Yanqing Li; Lin Xi; Hongfei Lou; Meiping Lu; Yuhui Ouyang; Wendan Shi; Xiaoyao Tao; Huiqin Tian; Chengshuo Wang; Min Wang; Nan Wang; Xiangdong Wang; Hui Xie; Shaoqing Yu; Renwu Zhao; Ming Zheng; Han Zhou; Luping Zhu; Luo Zhang
Journal:  Allergy Asthma Immunol Res       Date:  2018-07       Impact factor: 5.764

7.  Innate Lymphoid Cells in Airway Inflammation.

Authors:  M Asghar Pasha; Qi Yang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.

Authors:  Chang Zeng; Simone Vanoni; David Wu; Julie M Caldwell; Justin C Wheeler; Kavisha Arora; Taeko K Noah; Lisa Waggoner; John A Besse; Amnah N Yamani; Jazib Uddin; Mark Rochman; Ting Wen; Mirna Chehade; Margaret H Collins; Vincent A Mukkada; Philip E Putnam; Anjaparavanda P Naren; Marc E Rothenberg; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2018-05-04       Impact factor: 10.793

9.  Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin.

Authors:  Sucai Liu; Mukesh Verma; Lidia Michalec; Weimin Liu; Anand Sripada; Donald Rollins; James Good; Yoko Ito; HongWei Chu; Magdalena M Gorska; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2017-04-20       Impact factor: 10.793

Review 10.  Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease.

Authors:  Maya R Karta; David H Broide; Taylor A Doherty
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.